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engagement. ConClusions: The evidence-based market access value resource 
approach provides a clear, concise, and globally integrated value story that will 
assist in market access and form the basis of consistent communication regarding 
value at the national, regional, and local level across external stakeholders (e.g., 
payer decision makers, physicians, patient advocates). Access for a biologics will be 
complex; regardless of pathway, decisions regarding reimbursement and adoption 
of a new technology are diverse and dispersed across and within countries, with 
varying levels of required evidence.
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The US significantly outspends all other top 10 developed nations, with no increase 
in life expectancy. Increasing transparency in health care spending could help 
address this cost to outcomes gap. CMS’ recent release of Medicare Part B Utilization 
and Payment data, covering 880,000 providers and $77 billion in Medicare pay-
ments, is a significant step toward this goal. objeCtives: Understand differences 
in billed versus paid amounts for provider and procedure types reported in Medicare 
data. Methods: Descriptive and inferential statistics were run on provider spe-
cialties representing greater than 2% of claims to describe the differences between 
maximum allowed Medicare payment amount, amount billed by providers, and 
the amount reimbursed. Geographical variation was also explored. Results: 
Amount billed is at least double the amount paid and double the maximum allow-
able amount for all of the specialties explored; amount billed versus paid varies 
significantly by specialty, with some specialties billing as much as six times what 
they are paid. Largest discrepancies were in anesthesiology (on average billing $838, 
versus $139 allowed and $110 paid). Other specialties with significant disparity 
include cardiology, diagnostic radiology, emergency medicine, ophthalmology, and 
orthopedic surgery; within certain specialties, specific procedures showed ranges 
of billing and payment ratios; across all specialties, average amount paid was about 
90% of maximum allowable; and each state is represented in line with census data 
for the Medicare population; state differences in amount paid versus billed and 
allowed is not significant. ConClusions: In analyzing payer and provider data to 
increase transparency on health care spend, we recognize there is heterogeneity 
between what is paid versus billed across specialty. There is an opportunity to focus 
attention on narrowing this gap for high-value procedures through evidence and 
education of patients, payers, and providers to ensure patients receive appropriate 
treatment, and providers are appropriately reimbursed.
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objeCtives: To assess the value and service quality of the National Health 
Insurance Scheme (NHIS) benefits. Methods: A review method was employed 
to analysis medical claims for the 2011 to 2013 period. The medical claims were 
retrieved from the database of the Ashiedu Keteke District NHIS Office. The incurred 
claims ratio, promptness of claims settlement, and claims rejection ratio indicators 
of benefit value and service quality were analyzed. Results: A total of 421,574 
medical claims with a cost of GHS7.3 million (USD2.6 million) were analyzed. 
These claims came from thirteen accredited health care providers-three public 
health facilities, four private clinics and six community pharmacies. The incurred 
claims ratio increased significantly from 4.3 to 7.2 over the period, 2011-2013. The 
proportion of claims settled beyond 90 days increased consistently from 26% to 
90% over the same period. Although, the proportion of claims rejected increased 
from 0.9% to 3.6% over the period under review, overall, it was low. The reasons for 
rejection included provision of benefits to inactive subscribers and breach of sub-
limit on certain expense category. ConClusions: There is increased awareness 
and utilization of health services; however, there are considerable delays in claims 
settlements. It would be necessary for management of the NHIS to settle claims 
in time to ensure that health care providers are financially resourced to render 
service to subscribers.
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objeCtives: Our team wanted to compare the economic effect of restricted mar-
ket access and reference based pricing (RBP) vs. RBP alone in two consecutive 
periods, 2007—2009 and 2010—2012. Methods: We used the officially published 
cash flow statements and income statements from the financial reports of the 
National Health Insurance Fund (NHIF) for each of the years from 2007 to 2012. 
Then we compared the data about the expenditure for drugs, as well as the data 
about the budget control. Results: While restricted market access and RBP has 
been applied between 2007 and 2009, the NHIF drug expenditure increased with 
15% (from EUR 144 mln to EUR 166 mln). For that period, the drug expenditure 
was generally 100% within the budget. From 2010 to 2012, while only RBP has been 
applied, the expenditure increased with 62% (from EUR 187 to EUR 303 mln). For 
the period, the drug expenditure exceeded the NHIF budget with 5% in 2010, 34% in 
2011, 20% in 2012. ConClusions: RBP alone cannot control the drug expenditure 
in a long-term. Additional measures are needed together with RBP. Performance-
based pricing, differential pricing, comparative pricing, profit control and price-
volume agreements may be considered as additional to RBP measures for pricing 
and budget control.
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objeCtives: The part of Hungarian drug provision system, which is available 
on social welfare list, changed several times and in different extents in recent 
years. The introduction of drug budget in 2006 and simultaneously the abolition 
of social welfare drug list implied the most significant change. The chief aim of 
our analysis to give a comprehensive overview about the main trends on this field 
examining the range of available products on social welfare list based on different 
aspects, also concerning the trends of demand, product structure, expenditures 
and patient burdens. Methods: Changes of key points of relevant acts concerned 
in drug provision, the aggregated (not patient level) public turnover data of the 
Hungarian Health Fund and published number of patients involved in this reim-
bursement category were considered as the key sources and indicators of our 
evaluation. Results: After regulation changes, demand (DOT) and number of 
patients within social welfare list category significantly decreased after 2006 until 
2009, but since then both of them stagnate. Significant growth of reimbursement 
outflow within this segment can be observed until 2011, but after slight decrease. 
Part share of higher level reimbursement categories within reimbursement out-
flow increased. Demand moved to more expensive products, while patients were 
able to access to more innovative active ingredients in higher level reimburse-
ment categories. Strong correlation can be observed between changes of acts and 
breaks in turnover trends. ConClusions: Results of the analysis may support 
objective judgement of the present social welfare provision system, as well as 
may contain considerable consequences regarding to potential ways of future 
structural changes, considering both interests of entitled patients (right to access 
innovative therapies) and the Health Fund (increase savings, improve efficiency). 
Further analysis based on real world (patient level) data may result more complex 
investigation opportunities of this patient segment and reimbursement category.
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objeCtives: This study aims to determine if the recently proposed model for thera-
peutic positioning reports (IPTs) in Spain is actually being used as a supportive 
tool for pharmaceutical pricing and reimbursement (P&R) decisions whilst deliver-
ing greater transparency and regional market access harmonisation. Methods: 
Primary research was conducted with regional payers on the proposed model of 
IPTs, which contain a comparative evaluation on effectiveness and safety, as well 
as criteria of use, for newly authorized medicines and older medicines which have 
a high potential health or economic impact. This was supplemented by secondary 
research. Results: The publication of IPTs has brought quicker uptake and greater 
homogenization to the market access of certain medicines. Notably, according to 
primary research, protease inhibitors were made available in all autonomous com-
munities (CCAAs) two months after the IPT publication. However, the deadline of 3 
months for the publication of IPTs is generally not being met. As delineated in the 
model and shown by primary research, IPTs are starting to be used as a basis for 
P&R decision-making in Spain and play an important role in the identification of 
the most suitable target patient population. IPTs are also delivering on promises 
of generating consensus amongst the Spanish CCAAs. ConClusions: IPTs are 
being used to support the Inter-ministerial Commission of Medicine Prices and 
the Directorate General of Pharmacy and Basic Services role in P&R. If accepted 
by the majority of the CCAAs, IPTs will also serve as a tool to evaluate and limit 
discrepancies in innovative medicines access throughout Spain. However, there is 
lack of consensus of whether an IPT should include an economic evaluation from 
the start. Contrary to manufacturers, regional payers generally believe its inclusion 
would help with the selection of more cost-effective medicines whilst aiding with 
the adoption of IPTs in general.
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objeCtives: Referral utilization is defined as the number of patients referred and 
seen by physicians. The objective was to establish referral utilization rate among sick 
persons identified at the households, counseled and referred to link hospitals by com-
munity health workers. Sick persons identified were issued with referral and counter 
referral slips to take to the hospital. Methods:  This was a quasi -experimental study 
carried out in two sub- locations in rural Kenya. One hundred community health 
workers were trained on community based referral and counter referral model and 
issued with referral tools. Each was assigned 25 households, instructed to regularly 
visit them in order to identify sick persons, counsel and refer them to link hospitals for 
care. One hundred villages comprising 2209 households with a population of 11,000 
people were covered and referral model implemented for 12 months. Results: A 
total of 322 patients were identified, advised and referred, with a referral response 
rate of 93% (298/322.) Seventy percent were five years and above. The study showed 
that 82% (263/322) of the patients arrived in hospital with referral slip the same day 
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they were referred, 5% (15/322) arrived the second day, 6% (20/322) third day and over 
and 7% (24/322) did not arrive in the hospital. ConClusions: The study provides 
evidence that community health workers if properly trained, equipped and supported 
would identify sick persons in the households, counsel and refer them to hospitals for 
specialized care. Patient referral arrival rate on same day is reasonably high because 
households were regularly visited and sick persons encouraged to seek care. Similar 
studies carried out in the US and Great Britain suggest that in a population of 1000 
adults, 750 will experience an episode of illness, of these 250 will consult a physician 
of whom 6 will require to be referred to the physician.
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objeCtives: To improve health care provision whilst containing cost at the same 
time, Chinese authorities allow the entry of new drugs at provincial level. Whilst 
different provinces have different economic situation and needs, it is essential for 
pharmaceutical companies to strategize provincial drug entry. The purpose of this 
research is to explore province(s) that may provide the best chance for new drug 
entry. Methods: To capture all the drugs that were newly included in the 2012 
National Drug List (NDL) but not the 2009 NDL, multiple databases including the two 
NDLs, Adis Insight and the Chinese database Yao-zhi Shu-ju were used. Provincial 
reimbursement status of these drugs was identified using the Chinese database. 
Provincial population and economic data (including gross domestic product (GDP), 
health expenditure and consumer price index (CPI)) in 2011 were captured on the 
National Statistical Database. The correlation between the numbers of provincially 
reimbursed drugs (with/without restrictions) and GDP per capita, and between the 
numbers of provincially reimbursed drugs (with/ without restrictions) and regional 
health expenditure, were investigated. All databases were accessed in September 
2013. Results: 245 new formulations were identified, among which 35 of them are 
alternative formulations of 26 new drugs. Among the 23 provinces and 4 municipali-
ties provinces, Anhui (48%) followed by Jiangsu (20%) approved most new drugs with-
out restrictions. Guangxi (21%) was the autonomous region approved most new drugs 
without restrictions. Among the provincially reimbursed drugs, Jilin (62%) was the 
province approved most drugs associated with restrictions. The number of approved 
drugs was not correlated to regional GDP per capita (p= 0.18, r2= 0.06) nor with regional 
health expenditure (p= 0.78, r2= 0.003). ConClusions: There is a substantial variation 
in the number of approved new drugs between provinces in China. The economic 
status of the provinces is not likely to be the sole factor causing such differentiation.
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objeCtives: The availability of concentrated big data sets can help researchers 
analyze current trends in an industry and drive future growth. Over 1,600 poster 
presentations related to pharmacoeconomics and outcomes research were pre-
sented at the 2013 ISPOR European meeting. We analyzed the titles of the posters to 
find trends in research. Methods: We analyzed the titles and associated sections 
of all the poster presentations accepted for the ISPOR 2013 European meeting held 
in Dublin, Ireland. The distribution by sector (research on methods, health care use 
& policy studies, cancer, cardiovascular, etc) was calculated in addition to the type 
of study (cost, PRO & patient preference, clinical outcomes, etc.). We also searched 
the titles of posters for key words to divide studies into the following four categories: 
cost-effectiveness, budget-impact, burden of illness and literature review. Results: 
In total, 1,679 poster title were analyzed. For the sector distribution, the top three 
studies were as follows: research on methods (238; 14.18%), health care use & policy 
studies (217; 12.92%) and cancer (210; 12.51%). The most popular types of studies 
were: cost studies (617; 36.75%), patient reported outcome & patient preference 
studies (212; 12.63%), and clinical outcomes studies (200; 11.91%). Of all the posters, 
cost-effectiveness studies made up 12.27%, while budget impact studies, literature 
reviews and burden of illness studies made up 2.5%, 1.67% and. 6%, respectively. The 
top three sectors for cost-effectiveness studies were cancer (31; 15.05%), cardiovas-
cular disorders (29; 14.08%), and infections (28; 13.59%). ConClusions: Analyzing 
trends at conferences may help researchers and key stakeholders understand the 
current issues in the field. The most common type of study for the 2013 ISPOR 
European were cost studies. The cost-effectiveness studies were concentrated in 
cancer, cardiovascular disorders and infections.
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objeCtives:  To determine common illnesses identified and referred to the health 
facility for care by community health workers during routine household visita-
tions. Methods: Quasi-experimental study was carried out in two sub-locations 
in rural Kenya where one hundred community health workers were trained on 
community based referral and counter referral model and issued with referral 
tools. Each was assigned 25 households, instructed to regularly visit them in order 
to identify sick persons counsel and refer them to link hospitals. One hundred 
villages comprising 2209 households with a population of 11,000 people were 
covered where the counter referral model was implemented. Results: In total 
the community health workers identified, counseled and referred 322 sick per-
sons to health facilities for health care. Those identified for referrals were cat-
egorized as either below or above five years. Under fives referrals accounted for 
30% (97/322) where the top five reasons for referrals included; general illnesses for 
under fives, 5.2 (18%); postnatal care for infant, 30 (9.3%); immunization defaulters 
(3.1%); malaria, 3 (. 9%) and diarrhea, 3 (. 9%). Top five reasons for above five refer-
rals included; general illnesses for above fives, 89 (27.6%); ANC clinic 34, (12.7%); 
health check up, 24 (7.5%); Chronic cough, 19 (5.9%) and PNC for mother 6 (1.9%.)  
ConClusions: Community Health Workers were able to identify, counsel and 
refer 322 persons with 38 various types of ailments. The study concludes that 
if CHWs are trained well, supplied with referral tools and provided with regu-
lar support supervision, they have the capacity to identify common ailments at 
household level and provide advice on the appropriate health action required to 
be taken. It is the view of the authors that community health workers referral 
model be scaled up.
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objeCtives: To evaluate patients’ satisfaction with the general practice care pro-
vided at the Pafos General Hospital outpatient units. Methods: The EUROPEP ques-
tionnaire, standardized and validated into Greek, was distributed to outpatients, 
with the method of random sampling and filled out with personal interviews, from 
February to April 2014. EUROPEP includes 23 items and 5 dimensions regarding 
doctor – patient relationship, medical care, information - support, organization of 
care and accessibility. The sample size was based on 50% of annual outpatients’ 
visits. For the assessment of the questionnaire internal consistency, the coefficient 
a Cronbach was used. Student’s t-test and analysis of variance have been performed 
in order to determine the significant differences between the dimensions and soci-
odemographic characteristics. Results: In total 345 out of 383 outpatients filled 
out the questionnaire (RR= 90%). The majority of the sample (61.2%) was female and 
belonged to the 61-80 years old group. 43.5% of sample answered moderate health 
condition and 43.8% bad. The Cronbach’s alpha of questionnaire met the criterion 
of 0.858. The doctor – patient relationship, medical care, information – support 
and organization of care scored 4.09±1, 3.56±0.8, 3.97±0.9 and 4.01±1.2 respectively, 
which mean ‘satisfied’. However, the accessibility regarding the getting through to 
the practice and waiting time was scored much lower (2.3 ±0.8), meaning ‘dissatis-
fied’. Statistically significant differences were found between gender and doctor – 
patient relationship (p= 0.019), information - support (p≤ 0.001) and organization of 
care (p= 0.003), while age group was related to information – support (p≤ 0.001) and 
organization of care (p≤ 0.001). Patients’ health condition was found significant with 
the doctor – patient relationship (p= 0.004), medical care (p= 0.007) and accessibil-
ity (p= 0.001). ConClusions: Patients were satisfied with the provision of general 
practice and sociodemographic characteristics appear to be significant predictors of 
satisfaction. Also, problems of accessibility can be solved through the forthcoming 
reform of primary health care in Cyprus.
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objeCtives: Clinical trials (CTs) lead to innovative medical treatments, and pre-
sent positive externalities both for clinical practice and the economy. The study 
aimed at portraying the CT activity in Greece for 2012, built upon a previous survey 
conducted in 2010, and at highlighting any discrepancies. Methods: The survey 
was conducted among the members of the Hellenic Association of Pharmaceutical 
Companies (SFEE). Each company was requested to return a structured ques-
tionnaire for each interventional CT approved by the National Ethics Committee 
(NEC) during 2012. Questionnaire items focused on the main characteristics of 
each CT: duration, phase, budget, number of recruited patients, affiliation of 
recruiting sites and therapeutic area of the investigational agent. Results: All 
SFEE members participated returning completed questionnaires (response rate: 
100%). Data on 70 interventional CTs were received. The majority was phase-III 
trials (64.3%) as in 2010 (68.3%) with a mean duration of 36.3 months (regardless 
of phase). Most CT sites were affiliated to a university or NHS hospital (45.7% and 
42.3% respectively). A contractionary phase in the CT activity was observed com-
pared to 2010, as demonstrated by the basic characteristics of approved CTs, i.e. 
average number of patients/trial: 35 vs 98, average number of patient per partici-
pating center: 8.68 vs 32.5, average total budget/trial 218,556€ vs 296,598€ for 2012 
vs 2010 respectively. ConClusions: In 2012, the health care sector in Greece 
entered a recession phase due to the severe economic crisis and the subsequent 
fiscal adjustment program. These measures, accompanied by non-efficient pro-
cesses in the administrative setting for CT approvals in Greece, appear to have an 
impact on the country’s CT activity. Given that CTs represent vital investments 
for the human capital and the economy, joint action from all stakeholders is 
of paramount importance in order to surpass existing hurdles and to promote 
investment in research.
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objeCtives: To investigate factors affecting nurses’ working motivation on job 
satisfaction in public and private hospitals in Pafos. Methods: The study included 
all hospitals in Pafos, with 410 nurses out of which a random sample was col-
lected from February to March 2013. Two generic, self-administered, instruments 
have been used. The first questionnaire refers to working motivation in terms of 
recognition, responsibility, personal development, job interest, working relation-
ships etc, developed by Everard κ α ι Morris (1999). The second instrument refers to 
job satisfaction by Spector (1985). Both instruments score 1: “agree/satisfied very 
